Article
San Francisco - Molecular definition of cancer antigens has opened new possibilities for developing effective adjuvant melanoma immunotherapies, according to Steven A. Rosenberg, M.D., Ph.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.